Mylan Pharmaceuticals, Inc. (December 29, 2011)

Hospira Inc. (December 12, 2011)

Johnson Matthey, Inc. (December 12, 2011)

Fisher Clinical Services, Inc. (October 7, 2011)

Cody Laboratories Inc. (October 7, 2011)

Cambrex Charles City, Inc. (August 18, 2011)

Cambrex Charles City, Inc. (August 18, 2011)

Aptuit (August 18, 2011)

Roche Diagnostics Operations Inc. (July 19, 2011)

United States Pharmacopeial Convention (July 19, 2011)

Research Triangle Institute (July 5, 2011)

Penick Corporation (June 16, 2011)

Boehringer Ingelheim Chemicals, Inc. (June 16, 2011)

Noramco Inc. (June 16, 2011)

Lipomed, Inc. (June 16, 2011)

Wildlife Laboratories (June 16, 2011)

Chattem Chemicals Inc. (June 16, 2011)

Noramco Inc. (June 16, 2011)

AllTech Associates Inc. (June 9, 2011)

Almac Clinical Services Inc. (ACSI) (May 27, 2011)

Akorn, Inc. (May 27, 2011)

Rhodes Technologies (May 4, 2011)

Stepan Company (April 19, 2011)

Meda Pharmaceuticals Inc. (April 19, 2011)

Aptuit (March 17, 2011)

Sigma Aldrich Manufacturing LLC. (Correction) (March 4, 2011)

Sigma Aldrich Manufacturing LLC. (February 23, 2011)

Mallinckrodt Inc. (February 2, 2011)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).